A former employee of the Aptuit clinical research organization was found guilty of altering pre-clinical trial data that was used to support applications to perform clinical trials, according to the UK’s Medicines and Healthcare products Regulatory Agency. The MHRA noted this was the first instance in which Good Laboratory Practice Regulations were used to pursue such a prosecution. The probe into Steven Eaton began when Aptuit identified serious irregularities in pre-clinical data and informed the agency. Dating back to 2003, he began selectively reporting used to assess whether analytical methods were working properly or to assess the concentration of the drug in blood. The data manipulation ensured an experiment was deemed successful, when it actually had failed, the MRHA notes.